Clinical Trial Update: Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients

View source ↗

Summary

This completed clinical trial evaluated management of heparin-induced thrombocytopenia in liver transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia
• Liver Transplantation

Snippet

Sponsor: CHIR-Net | Conditions: Heparin-induced Thrombocytopenia, Liver Transplantation | Status: COMPLETED